News & Events
WHO’s decision brings hope to people with MS worldwide
Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time
Is it MS or something else?
Global MS experts update recommendations for the differential diagnosis of MS
Professor Xavier Montalban wins the prestigious MS Charcot Award
Professor Montalban wins the 2023 lifetime achievement award for outstanding research into the understanding and treatment of…
Global webcast on ending MS progression
Research advances that could lead to breakthrough treatments in progressive MS
Global barriers to MS diagnosis
Importance of training and education for healthcare professionals is highlighted in new publication
Tawasol – June 2023 issue
Your update from MS organisations in the Arab Region
MS organisations commit to a shared global research strategy to accelerate cures for MS
Agreement seeks to coordinate resources on the highest potential research
MSIF emphasises need for treatments for neurological conditions during WHO meeting
MSIF and neurological organisations' statement during the Essential Medicines List Committee open session
National advocacy with the MS Society of India
A look at some of MSSI’s most exciting advocacy work and MSIF’s visit to Delhi and Mumbai.
Visiting MS organisations in the Middle East and North Africa
MSIF’s Organisational Development and Movement Building (ODMB) team visited MS organisations in Egypt and Jordan to learn…
Adapting digital fundraising to our reality
Digital fundraising learnings from MS organisations in Latin America
BARCODING MS initiative wins the Italian MS Society a prestigious award
Congratulations to our member organisation in Italy on their award for best practice in collecting and sharing…